4Gamberi G, Benassi MS, Bohling T. C-myc and c-fos in human osteosarcoma :prognostic value of mRNA and protein expression [ J ]. Oncology, 1998,55 (6) :556 - 563.
5Maitra A,Wanzer D,Weinberg AG et al. Amplification of the HER-2/neu oncogene is uncommon in pediatric ostcosarcomas[ J]. Cancer,2001,92(3) :677 -683.
6Thomas DG,Giordano TI, Sanders D, et al. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma [ J ].Clin Cancer Res,2002,8(3) :788 -793.
7Asada N ,Tsuchiya H,Tomita K. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line[ J]. Anticancer Res (Br) , 1999,19 ( 6 ) :5131 -5137.
8Amir G, Issakov J, Meller I, et al. Expression of p.53 gene product and cell proliferation marker K/-67 in Ewing's sarcoma: correlation with clinical outcome [ J ]. Hum Pathol,2002 ,33 (2) : 170 - 174.
9Teixeira CR,Tanaka S, Hm'uma K, et al. Proliferating Cell Nuclear Antigen Expression at the Invasive Tumor Margin predicts Malignant Potential of Colorectal Carcinomas [ J ]. Cancer, 1994,73:575.
10Tarkkanen M ,Wiklund TA, Virolainen MJ,et al. Comparative genomic hybridization of postirradiation sarcomas [ J ]. Cancer, 2001,92(7) :1992 ~ 1998.
二级参考文献9
1[1]Schajowicz F,Histological typing of bone tumors. WHO intern Histological classification of tumor.2nd ed. Geneva:World Health organization, 1993.
2[2]Hasegawa T,Fujii Y,Seki K,et al. Epitheloid angiosarcoma of bone. Human Pathol, 1997,28:985-989.
3[3]Bertoni F. Osteosarcoma-Low grade intraosseous type osteosarcoma histologically resembling parosteal osteosarcoma, fibrous dysplasia and desmoplastic fibroma. Cancer, 1993,71:338-340.
4[4]Sudilovsky D,Johnson,JO,Zaloudek C.Intracortical osteosarcoma. A case report and review of literature. Intern J Surg Pathol, 1996,3:195-200.
5[5]Dehher LP. Primitive neuroctodermal tumor and Ewing's sarcoma. Am J Surg Pathol, 1993,17:1-13.
6[6]Campanacci M, Laus M. Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg(Am), 1981,63:367-375.
